Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbora Paldus

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Diabetes Care|November 18, 2021
A Randomized Crossover Trial Comparing Glucose Control During Moderate-Intensity, High-Intensity, and Resistance Exercise With Hybrid Closed-Loop Insulin Delivery While Profiling Potential Additional Signals in Adults With Type 1 DiabetesBarbora Paldus, Dale Morrison, Dessi P Zaharieva, et al.
Diabetes Research and Clinical Practice|February 4, 2026
Survey of glucose levels in adults with T1DM attending clinic using automated insulin delivery (AID) devices compared with manual insulin deliveryKate M Seaton, Hanna C Jones, Melissa H Lee, et al.
BMJ Open Diabetes Research & Care|January 11, 2025
Six months of hybrid closed-loop therapy improves diabetes-specific positive well-being, and reduces diabetes distress and fear of hypoglycemia: secondary analysis of a randomized controlled trialJennifer A Halliday, Sienna Russell-Green, Benjamin Lam, et al.
Diabetes Technology & Therapeutics|February 14, 2022
Driving with Type 1 Diabetes: Real-World Evidence to Support Starting Glucose Level and Frequency of Monitoring During JourneysSteven Trawley, Amanda N Stephens, Sybil A McAuley, et al.
Diabetes Research and Clinical Practice|August 29, 2021
Meal-time glycaemia in adults with type 1 diabetes using multiple daily injections vs insulin pump therapy following carbohydrate-counting education and bolus calculator provisionJean C Lu, Sara Vogrin, Sybil A McAuley, et al.
Diabetes Technology & Therapeutics|December 22, 2020
Less Nocturnal Hypoglycemia but Equivalent Time in Range Among Adults with Type 1 Diabetes Using Insulin Pumps Versus Multiple Daily InjectionsSybil A McAuley, Sara Vogrin, Melissa H Lee, et al.
Diabetes Care|October 15, 2020
Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled TrialSybil A McAuley, Melissa H Lee, Barbora Paldus, et al.
Internal Medicine Journal|November 27, 2024
Results of an Australian trial of an automated insulin delivery (AID) system and other studies support likely benefit of AID use for many Australian adults with type 1 diabetesAlicia J Jenkins, Andrzej S Januszewski, Adrienne Kirby, et al.
BMJ Open|June 11, 2018
Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocolSybil A McAuley, Martin I de Bock, Vijaya Sundararajan, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Diabetes Care|November 18, 2021
A Randomized Crossover Trial Comparing Glucose Control During Moderate-Intensity, High-Intensity, and Resistance Exercise With Hybrid Closed-Loop Insulin Delivery While Profiling Potential Additional Signals in Adults With Type 1 DiabetesBarbora Paldus, Dale Morrison, Dessi P Zaharieva, et al.
Diabetes Research and Clinical Practice|February 4, 2026
Survey of glucose levels in adults with T1DM attending clinic using automated insulin delivery (AID) devices compared with manual insulin deliveryKate M Seaton, Hanna C Jones, Melissa H Lee, et al.
BMJ Open Diabetes Research & Care|January 11, 2025
Six months of hybrid closed-loop therapy improves diabetes-specific positive well-being, and reduces diabetes distress and fear of hypoglycemia: secondary analysis of a randomized controlled trialJennifer A Halliday, Sienna Russell-Green, Benjamin Lam, et al.
Diabetes Technology & Therapeutics|February 14, 2022
Driving with Type 1 Diabetes: Real-World Evidence to Support Starting Glucose Level and Frequency of Monitoring During JourneysSteven Trawley, Amanda N Stephens, Sybil A McAuley, et al.
Diabetes Research and Clinical Practice|August 29, 2021
Meal-time glycaemia in adults with type 1 diabetes using multiple daily injections vs insulin pump therapy following carbohydrate-counting education and bolus calculator provisionJean C Lu, Sara Vogrin, Sybil A McAuley, et al.
Diabetes Technology & Therapeutics|December 22, 2020
Less Nocturnal Hypoglycemia but Equivalent Time in Range Among Adults with Type 1 Diabetes Using Insulin Pumps Versus Multiple Daily InjectionsSybil A McAuley, Sara Vogrin, Melissa H Lee, et al.
Diabetes Care|October 15, 2020
Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled TrialSybil A McAuley, Melissa H Lee, Barbora Paldus, et al.
Internal Medicine Journal|November 27, 2024
Results of an Australian trial of an automated insulin delivery (AID) system and other studies support likely benefit of AID use for many Australian adults with type 1 diabetesAlicia J Jenkins, Andrzej S Januszewski, Adrienne Kirby, et al.
BMJ Open|June 11, 2018
Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocolSybil A McAuley, Martin I de Bock, Vijaya Sundararajan, et al.
Pageof 3